Magnetic Resonance Imaging in Locoregional Staging of Rectal Adenocarcinoma

Seminars in Ultrasound, CT and MRI

Volumn 29, Issue 6, 2008, Pages 433-453

  McMahon, Colm J ^a   Smith, Martin P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FUNCTIONAL ANATOMY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA;

ADENOCARCINOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RECTUM;

EID: 57049185809     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2008.10.008     Document Type: Article

References (141)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumors (2002), Wiley, New York, NY
3. Greene F.L., and Fleming I.D. AJCC Cancer Staging Manual. (ed 6). PD (2002), Springer, New York, NY
4. Jessup J.M., Stewart A.K., and Menck H.R. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-95. Cancer 83 (1998) 2408-2418
5. Kuo L.J., Liu M.C., Jian J.J., et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?. Ann Surg Oncol 14 (2007) 2766-2772
6. Arnoletti J.P., and Bland K.I. Neoadjuvant and adjuvant therapy for rectal cancer. Surg Oncol Clin North Am 15 (2006) 147-157
7. Glynne-Jones R., Mathur P., Elton C., et al. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer. Best Pract Res Clin Gastroenterol 21 (2007) 1049-1070
8. Rajput A., and Bullard Dunn K. Surgical management of rectal cancer. Semin Oncol 34 (2007) 241-249
9. Ramsey S., and Tepper J.E. Rectal cancer radiotherapy. Cancer J 13 (2007) 204-209
10. Tytherleigh M.G., Warren B.F., and Mortensen N.J. Management of early rectal cancer. Br J Surg 95 (2008) 409-423
11. Devereux D.F., and Deckers P.J. Contributions of pathologic margins and Dukes' stage to local recurrence in colorectal carcinoma. Am J Surg 149 (1985) 323-326
12. Adam I.J., Mohamdee M.O., Martin I.G., et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344 (1994) 707-711
13. Birbeck K.F., Macklin C.P., Tiffin N.J., et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235 (2002) 449-457
14. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2 (1986) 996-999
15. Taylor R.H., Hay J.H., and Larsson S.N. Transanal local excision of selected low rectal cancers. Am J Surg 175 (1998) 360-363
16. Chakravarti A., Compton C.C., Shellito P.C., et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg 230 (1999) 49-54
17. Sengupta S., and Tjandra J.J. Local excision of rectal cancer: what is the evidence?. Dis Colon Rectum 44 (2001) 1345-1361
18. Tjandra J.J., Kilkenny J.W., Buie W.D., et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 48 (2005) 411-423
19. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 (1986) 1479-1482
20. Reynolds J.V., Joyce W.P., Dolan J., et al. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 83 (1996) 1112-1115
21. Scott N., Jackson P., al-Jaberi T., et al. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 82 (1995) 1031-1033
22. Martling A.L., Holm T., Rutqvist L.E., et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 356 (2000) 93-96
23. Nesbakken A., Nygaard K., Westerheim O., et al. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 28 (2002) 126-134
24. Wibe A., Rendedal P.R., Svensson E., et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89 (2002) 327-334
25. Balch G.C., De Meo A., and Guillem J.G. Modern management of rectal cancer: a 2006 update. World J Gastroenterol 12 (2006) 3186-3195
26. Phang P.T. Total mesorectal excision: technical aspects. Can J Surg 47 (2004) 130-137
27. Maslekar S., Sharma A., Macdonald A., et al. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum 50 (2007) 168-175
28. Nagtegaal I.D., van de Velde C.J., van der Worp E., et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20 (2002) 1729-1734
29. Biggers O.R., Beart Jr. R.W., and Ilstrup D.M. Local excision of rectal cancer. Dis Colon Rectum 29 (1986) 374-377
30. Marr R., Birbeck K., Garvican J., et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242 (2005) 74-82
31. Nagtegaal I.D., van de Velde C.J., Marijnen C.A., et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23 (2005) 9257-9264
32. Wibe A., Syse A., Andersen E., et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior versus abdominoperineal resection. Dis Colon Rectum 47 (2004) 48-58
33. Mori T., Takahashi K., and Yasuno M. Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 383 (1998) 409-415
34. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240 (2004) 711-717 discussion 717-718
35. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
36. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
37. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer. V. 2.2008 (2008)
38. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
39. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
40. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
41. Guillem J.G., Diaz-Gonzalez J.A., Minsky B.D., et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 26 (2008) 368-373
42. Garcia-Aguilar J., Hernandez de Anda E., Sirivongs P., et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 46 (2003) 298-304
43. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 358 (2001) 1291-1304
44. Brown G., Richards C.J., Newcombe R.G., et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211 (1999) 215-222
45. Beets-Tan R.G., Beets G.L., Vliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357 (2001) 497-504
46. Blomqvist L., Holm T., Rubio C., et al. Rectal tumours-MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 38 (1997) 437-444
47. Gagliardi G., Bayar S., Smith R., et al. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg 137 (2002) 447-451
48. Poon F.W., McDonald A., Anderson J.H., et al. Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer. Eur J Radiol 53 (2005) 256-262
49. Bipat S., Glas A.S., Slors F.J., et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232 (2004) 773-783
50. Brown G., Radcliffe A.G., Newcombe R.G., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 (2003) 355-364
51. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 243 (2007) 132-139
52. Kim N.K., Kim M.J., Park J.K., et al. Preoperative staging of rectal cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 7 (2000) 732-737
53. Schnall M.D., Furth E.E., Rosato E.F., et al. Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings. Radiology 190 (1994) 709-714
54. Vliegen R.F., Beets G.L., von Meyenfeldt M.F., et al. Rectal cancer: MR imaging in local staging-is gadolinium-based contrast material helpful?. Radiology 234 (2005) 179-188
55. Cawthorn S.J., Parums D.V., Gibbs N.M., et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 335 (1990) 1055-1059
56. Willett C.G., Badizadegan K., Ancukiewicz M., et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?. Dis Colon Rectum 42 (1999) 167-173
57. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22 (2004) 1785-1796
58. Merkel S., Mansmann U., Papadopoulos T., et al. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer 92 (2001) 2754-1759
59. Beets-Tan R.G., Beets G.L., Borstlap A.C., et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?. Abdom Imaging 25 (2000) 533-541
60. Blomqvist L., Holm T., Nyren S., et al. MR imaging and computed tomography in patients with rectal tumours clinically judged as locally advanced. Clin Radiol 57 (2002) 211-218
61. Wittekind C.G.F., and Henson D.E. TNM Supplement: A Commentary on Uniform Use. (ed 3) (2003), Wiley-Liss, New York, NY
62. Shepherd N.A., Baxter K.J., and Love S.B. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112 (1997) 1096-1102
63. Pilipshen S.J., Heilweil M., Quan S.H., et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53 (1984) 1354-1362
64. Phang P.T., MacFarlane J.K., Taylor R.H., et al. Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes. Am J Surg 183 (2002) 504-508
65. Maier A.G., Kreuzer S.H., Herbst F., et al. Transrectal sonography of anal sphincter infiltration in lower rectal carcinoma. AJR Am J Roentgenol 175 (2000) 735-739
66. den Dulk M., Marijnen C.A., Putter H., et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 246 (2007) 83-90
67. Gavioli M., Losi L., Luppi G., et al. Preoperative therapy for lower rectal cancer and modifications in distance from anal sphincter. Int J Radiat Oncol Biol Phys 69 (2007) 370-375
68. Kim D.W., Lim S.B., Kim D.Y., et al. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur J Surg Oncol 32 (2006) 162-167
69. Zhou Z.G., Wang Z., Yu Y.Y., et al. Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases. World J Gastroenterol 9 (2003) 1477-1481
70. Nagtegaal I.D., and Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer?. J Clin Oncol 26 (2008) 303-312
71. Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26 (2002) 350-357
72. Caricato M., Borzomati D., Ausania F., et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 32 (2006) 126-132
73. Gosens M.J., Klaassen R.A., Tan-Go I., et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 13 (2007) 6617-6623
74. Nagtegaal I.D., Gosens M.J., Marijnen C.A., et al. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol 25 (2007) 1647-1650
75. Gosens M.J., van Krieken J.H., Marijnen C.A., et al. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. Clin Gastroenterol Hepatol 5 (2007) 997-1003
76. Wolberink S.V., Beets-Tan R.G., Nagtegaal I.D., et al. Preoperative assessment of the circumferential margin in rectal cancer is more informative in treatment planning than the T stage. Tech Coloproctol 10 (2006) 171-176
77. Lahaye M.J., Engelen S.M., Nelemans P.J., et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 26 (2005) 259-268
78. Bissett I.P., Fernando C.C., Hough D.M., et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 44 (2001) 259-265
79. Purkayastha S., Tekkis P.P., Athanasiou T., et al. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis 9 (2007) 402-411
80. Videhult P., Smedh K., Lundin P., et al. Magnetic resonance imaging for preoperative staging of rectal cancer in clinical practice: high accuracy in predicting circumferential margin with clinical benefit. Colorectal Dis 9 (2007) 412-419
81. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer. prospective observational study. BMJ 333 (2006) 779
82. Wieder H.A., Rosenberg R., Lordick F., et al. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival. Radiology 243 (2007) 744-751
83. Engelen S.M., Beets-Tan R.G., Lahaye M.J., et al. Location of involved mesorectal and extramesorectal lymph nodes in patients with primary rectal cancer: preoperative assessment with MR imaging. Eur J Surg Oncol 34 (2008) 776-781
84. Koh D.M., Brown G., Temple L., et al. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol 15 (2005) 1650-1657
85. Hocht S., Mann B., Germer C.T., et al. Pelvic sidewall involvement in recurrent rectal cancer. Int J Colorectal Dis 19 (2004) 108-113
86. Hojo K., Koyama Y., and Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 144 (1982) 350-354
87. Morikawa E., Yasutomi M., Shindou K., et al. Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 37 (1994) 219-223
88. Takahashi T., Ueno M., Azekura K., et al. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum 43 (2000) S59-S68
89. Ueno H., Mochizuki H., Hashiguchi Y., et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 245 (2007) 80-87
90. Sugihara K., Kobayashi H., Kato T., et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49 (2006) 1663-1672
91. Hida J., Yasutomi M., Fujimoto K., et al. Does lateral lymph node dissection improve survival in rectal carcinoma?. Examination of node metastases by the clearing method. J Am Coll Surg 184 (1997) 475-480
92. Brown G., Richards C.J., Bourne M.W., et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 227 (2003) 371-377
93. Arii K., Takifuji K., Yokoyama S., et al. Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbecks Arch Surg 391 (2006) 449-454
94. Kim J.H., Beets G.L., Kim M.J., et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 52 (2004) 78-83
95. Kim Y.H., Kim D.Y., Kim T.H., et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 761-768
96. Koh D.M., Chau I., Tait D., et al. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 71 (2008) 456-461
97. Allen S.D., Padhani A.R., Dzik-Jurasz A.S., et al. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 188 (2007) 442-451
98. Hoffmann K.T., Rau B., Wust P., et al. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 178 (2002) 386-392
99. Kuo L.J., Chern M.C., Tsou M.H., et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 48 (2005) 23-28
100. Chen C.C., Lee R.C., Lin J.K., et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 48 (2005) 722-728
101. Vliegen R.F., Beets G.L., Lammering G., et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 246 (2008) 454-462
102. Maretto I., Pomerri F., Pucciarelli S., et al. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 14 (2007) 455-461
103. Schaefer J.F., and Schlemmer H.P. Total-body MR-imaging in oncology. Eur Radiol 16 (2006) 2000-2015
104. Schaefer O., and Langer M. Detection of recurrent rectal cancer with CT. MRI and PET/CT. Eur Radiol 17 (2007) 2044-2054
105. Markus J., Morrissey B., deGara C., et al. MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 22 (1997) 338-342
106. Torricelli P., Pecchi A., Luppi G., et al. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 28 (2003) 19-27
107. Dicle O., Obuz F., and Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 72 (1999) 1155-1159
108. Blomqvist L., Ohlsen H., Hindmarsh T., et al. Local recurrence of rectal cancer: MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed tomography. Eur Radiol 10 (2000) 1383-1389
109. Krestin G.P., Steinbrich W., and Friedmann G. Recurrent rectal cancer: diagnosis with MR imaging versus CT. Radiology 168 (1988) 307-311
110. Titu L.V., Nicholson A.A., Hartley J.E., et al. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243 (2006) 348-352
111. Robinson P., Carrington B.M., Swindell R., et al. Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery. Clin Radiol 57 (2002) 514-522
112. Muller-Schimpfle M., Brix G., Layer G., et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology 189 (1993) 881-889
113. Blomqvist L., Fransson P., and Hindmarsh T. The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 8 (1998) 781-787
114. Kim M.J., Lim J.S., Oh Y.T., et al. Preoperative MRI of rectal cancer with and without rectal water filling: an intraindividual comparison. AJR Am J Roentgenol 182 (2004) 1469-1476
115. Slater A., Halligan S., Taylor S.A., et al. Distance between the rectal wall and mesorectal fascia measured by MRI: effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol 61 (2006) 65-70
116. Aitken C., Breen E., and Mamon H.J. Sphincter preservation therapy for rectal cancer. Clin Adv Hematol Oncol 1 (2003) 735-740
117. Zagoria R.J., Schlarb C.A., Ott D.J., et al. Assessment of rectal tumor infiltration utilizing endorectal MR imaging and comparison with endoscopic rectal sonography. J Surg Oncol 64 (1997) 312-317
118. Gualdi G.F., Casciani E., Guadalaxara A., et al. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum 43 (2000) 338-345
119. Maldjian C., Smith R., Kilger A., et al. Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: a comparison study to rectal endosonography. Abdom Imaging 25 (2000) 75-80
120. LeBlanc J.K. Imaging and management of rectal cancer. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 665-676
121. Matsuoka H., Nakamura A., Masaki T., et al. Comparison between endorectal coil and pelvic phased-array coil magnetic resonance imaging in patients with anorectal tumor. Am J Surg 185 (2003) 328-332
122. Tatli S., Mortele K.J., Breen E.L., et al. Local staging of rectal cancer using combined pelvic phased-array and endorectal coil MRI. J Magn Reson Imaging 23 (2006) 534-540
123. Brown G., Kirkham A., Williams G.T., et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 182 (2004) 431-439
124. Robbins S.E., and Virjee J. Applied radiologic anatomy. In: Butler P., Mitchell A.W.M., and Ellis H. (Eds) (1999), Cambridge University Press, Cambridge, MA 219-222
125. Beets-Tan R.G., Beets G.L., van der Hoop A.G., et al. High-resolution magnetic resonance imaging of the anorectal region without an endocoil. Abdom Imaging 24 (1999) 576-581 discussion 582-584
126. Talbot I.C., Ritchie S., Leighton M.H., et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg 67 (1980) 439-442
127. Bokey E.L., Ojerskog B., Chapuis P.H., et al. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg 86 (1999) 1164-1170
128. Smith N.J., Barbachano Y., Norman A.R., et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95 (2008) 229-236
129. Consorti F., Lorenzotti A., Midiri G., et al. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol 73 (2000) 70-74
130. Kanemitsu Y., Kato T., Hirai T., et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46 (2003) 160-167
131. Ho Y.H. Techniques for restoring bowel continuity and function after rectal cancer surgery. World J Gastroenterol 12 (2006) 6252-6260
132. Hoeffel C., Arrive L., Mourra N., et al. Anatomic and pathologic findings at external phased-array pelvic MR imaging after surgery for anorectal disease. Radiographics 26 (2006) 1391-1407
133. Ito K., Kato T., Tadokoro M., et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 182 (1992) 549-552
134. Messiou C., Chalmers A., Boyle K., et al. Surgery for recurrent rectal carcinoma: the role of preoperative magnetic resonance imaging. Clin Radiol 61 (2006) 250-258
135. Rao S.X., Zeng M.S., Chen C.Z., et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 65 (2008) 299-303
136. Dzik-Jurasz A., Domenig C., George M., et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360 (2002) 307-308
137. Kim J.K., Kim K.A., Park B.W., et al. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 28 (2008) 714-719
138. Lin G., Ho K.C., Wang J.J., et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 28 (2008) 128-135
139. Hein P.A., Kremser C., Judmaier W., et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 45 (2003) 214-222
140. Koh D.M., Brown G., Temple L., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 231 (2004) 91-99
141. Lahaye M.J., Engelen S.M., Kessels A.G., et al. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 246 (2008) 804-811